Syngene International Management
Management criteria checks 3/4
Syngene International's CEO is Jonathan Hunt, appointed in Jan 2016, has a tenure of 8.25 years. total yearly compensation is ₹84.75M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.088% of the company’s shares, worth ₹243.83M. The average tenure of the management team and the board of directors is 7.2 years and 6.8 years respectively.
Key information
Jonathan Hunt
Chief executive officer
₹84.8m
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 8.3yrs |
CEO ownership | 0.09% |
Management average tenure | 7.2yrs |
Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | ₹5b |
Sep 30 2023 | n/a | n/a | ₹5b |
Jun 30 2023 | n/a | n/a | ₹5b |
Mar 31 2023 | ₹85m | ₹85m | ₹5b |
Dec 31 2022 | n/a | n/a | ₹4b |
Sep 30 2022 | n/a | n/a | ₹4b |
Jun 30 2022 | n/a | n/a | ₹4b |
Mar 31 2022 | ₹76m | ₹76m | ₹4b |
Dec 31 2021 | n/a | n/a | ₹4b |
Sep 30 2021 | n/a | n/a | ₹4b |
Jun 30 2021 | n/a | n/a | ₹4b |
Mar 31 2021 | ₹65m | ₹65m | ₹4b |
Dec 31 2020 | n/a | n/a | ₹4b |
Sep 30 2020 | n/a | n/a | ₹4b |
Jun 30 2020 | n/a | n/a | ₹4b |
Mar 31 2020 | ₹66m | ₹66m | ₹4b |
Dec 31 2019 | n/a | n/a | ₹4b |
Sep 30 2019 | n/a | n/a | ₹4b |
Jun 30 2019 | n/a | n/a | ₹3b |
Mar 31 2019 | ₹90m | ₹47m | ₹3b |
Dec 31 2018 | n/a | n/a | ₹3b |
Sep 30 2018 | n/a | n/a | ₹3b |
Jun 30 2018 | n/a | n/a | ₹3b |
Mar 31 2018 | ₹94m | ₹47m | ₹3b |
Compensation vs Market: Jonathan's total compensation ($USD1.02M) is above average for companies of similar size in the Indian market ($USD562.53K).
Compensation vs Earnings: Jonathan's compensation has been consistent with company performance over the past year.
CEO
Jonathan Hunt (54 yo)
8.3yrs
Tenure
₹84,750,000
Compensation
Mr. Jonathan Brittan Hunt serves as the Managing Director of Syngene International Limited since April 1, 2020. He has been the Chief Executive Officer of Syngene International Ltd. since January 2016 and...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, CEO & Executive Director | 8.3yrs | ₹84.75m | 0.088% ₹ 243.8m | |
CFO & Executive Director | 4.3yrs | ₹34.14m | 0.017% ₹ 47.7m | |
Head of Investor Relations | no data | no data | 0.0013% ₹ 3.6m | |
Company Secretary & Compliance Officer | 4.8yrs | ₹4.72m | 0.0031% ₹ 8.7m | |
Head of Corporate Communications | no data | no data | no data | |
Chief Human Resources Officer | 1.3yrs | no data | no data | |
Head of Pharmaceutical & Biopharmaceutical Development | no data | ₹10.80m | no data | |
Head of Formulations Development | no data | ₹5.50m | 0.029% ₹ 81.5m | |
Head of IT | 8.2yrs | no data | 0.00038% ₹ 1.1m | |
Head of Discovery Biology | 8.3yrs | no data | 0.0060% ₹ 16.8m | |
Head of Clinical Development & Stability Studies | 8.3yrs | no data | 0.0048% ₹ 13.5m | |
Head of EHSS | 6.3yrs | no data | 0.0064% ₹ 17.7m |
7.2yrs
Average Tenure
Experienced Management: 539268's management team is seasoned and experienced (7.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, CEO & Executive Director | 6.9yrs | ₹84.75m | 0.088% ₹ 243.8m | |
CFO & Executive Director | no data | ₹34.14m | 0.017% ₹ 47.7m | |
Non-Executive Director | 23.7yrs | ₹7.25m | 0.0022% ₹ 6.2m | |
Non-Executive Chairperson | no data | ₹8.23m | 0.0055% ₹ 15.4m | |
Lead Independent Director | 6.8yrs | ₹7.57m | no data | |
Independent Director | 7.1yrs | ₹6.93m | 0.013% ₹ 35.1m | |
Additional Independent Director | less than a year | no data | no data | |
Independent Non Executive Director | 2.8yrs | ₹5.61m | no data | |
Non-Executive Independent Director | 9.7yrs | ₹7.91m | 0.013% ₹ 35.1m | |
Additional Independent Director | 4.7yrs | ₹7.57m | no data |
6.8yrs
Average Tenure
62yo
Average Age
Experienced Board: 539268's board of directors are considered experienced (6.8 years average tenure).